A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

July 13, 2018

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Advanced Solid Tumors
Interventions
DRUG

ABBV-155

Intravenous (IV) Infusion

DRUG

Paclitaxel

Intravenous (IV) Infusion

DRUG

Docetaxel

Intravenous (IV) Infusion

Trial Locations (40)

100

National Taiwan University Hospital /ID# 205673, Taipei City

704

National Cheng Kung University Hospital /ID# 206304, Tainan City

3000

Peter MacCallum Cancer Center /ID# 241676, Melbourne

10408

National Cancer Center /ID# 241095, Goyang-si

21224

Johns Hopkins Bayview Med Cnt /ID# 215095, Baltimore

21287

Johns Hopkins Hospital /ID# 201320, Baltimore

28040

Hospital Universitario Fundacion Jimenez Diaz /ID# 239997, Madrid

28041

Hospital Universitario 12 de Octubre /ID# 239999, Madrid

28078

Carolina BioOncology Institute /ID# 201577, Huntersville

32803

AdventHealth Orlando /ID# 227242, Orlando

35233

University of Alabama at Birmingham - Main /ID# 214024, Birmingham

40447

China Medical University Hospital /ID# 214062, Taichung

44106

Univ Hosp Cleveland /ID# 201567, Cleveland

48202

Duplicate_Henry Ford Hospital /ID# 226852, Detroit

72762

Highlands Oncology Group, PA /ID# 201568, Springdale

75230

Mary Crowley Cancer Research /ID# 214168, Dallas

77030

MD Anderson Cancer Center /ID# 201558, Houston

78229

NEXT Oncology /ID# 204893, San Antonio

80045

Univ of Colorado Cancer Center /ID# 208365, Aurora

90048

Duplicate_Cedars-Sinai Medical Center-West Hollywood /ID# 204267, West Hollywood

3109601

Rambam Health Care Campus /ID# 230813, Haifa

5265601

The Chaim Sheba Medical Center /ID# 230812, Ramat Gan

92868-3201

UC Irvine Medical Center - Chao Family Comprehensive Cancer Center /ID# 206105, Orange

06510-3206

Yale University, Yale Cancer Center /ID# 201542, New Haven

60611-2927

Northwestern University Feinberg School of Medicine /ID# 201563, Chicago

02215

Dana-Farber Cancer Institute /ID# 201564, Boston

11042-2060

Northwell Health - Marcus Ave /ID# 204376, New Hyde Park

73104-5418

University of Oklahoma, Stephenson Cancer Center /ID# 206820, Oklahoma City

02903-4923

Lifespan Cancer Institute at Rhode Island Hospital /ID# 204256, Providence

37232-0021

Vanderbilt Ingram Cancer Center /ID# 201575, Nashville

T6G 1Z2

Cross Cancer Institute /ID# 213838, Edmonton

M5G 2M9

University Health Network_Princess Margaret Cancer Centre /ID# 204539, Toronto

277-8577

National Cancer Center Hospital East /ID# 215130, Kashiwa-shi

104-0045

National Cancer Center Hospital /ID# 215003, Chuo-ku

6229 HX

Maastricht Universitair Medisch Centrum /ID# 225220, Maastricht

1066 CX

Antoni van Leeuwenhoek /ID# 222260, Amsterdam

3015 CE

Erasmus Medisch Centrum /ID# 222341, Rotterdam

3584 CX

Universitair Medisch Centrum Utrecht /ID# 222357, Utrecht

00935

Pan American Center for Oncology Trials, LLC /ID# 232128, Rio Piedras

03722

Yonsei University Health System Severance Hospital /ID# 240648, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY